Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-22-000137

Chief R&D Officer gave up 286 shares (to pay taxes)

  • Chief R&D Officer acquired 1,150 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scopelianos Angelo Chief R&D Officer 2022-12-27 Option exercise +1,150 26,244 D
Scopelianos Angelo Chief R&D Officer 2022-12-27 Shares withheld for taxes −286 $9.44 $2,700 25,958 D
Derivatives
Scopelianos Angelo Chief R&D Officer 2022-12-27 Option exercise · Restricted Stock Units +1,150 0 D
Loading xslF345X03/wf-form4_167236440298967.xml…